TMR Turbo-Misch- und Rühranlagen GmbH & Co. KG

New approach to the sensible utilisation of carbon dioxide from car exhaust gases - "A method has been discovered that uses impure CO2 streams and enables a breakthrough in the synthesis of valuable chemicals and pharmaceuticals"

Go to page

Acambis completes enrollment of Phase 3 JE vaccine trials ahead of schedule

Go to page

Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates - Company continues Development of Two Investigational Therapeutic Candidates

Go to page

American Peptide Company Announces Expansion of Its GMP Manufacturing Facility - Company expands capacity to accommodate large scale peptide production for growing customer base

Go to page

New biotech company Confo Therapeutics launched by VIB and Vrije Universiteit Brussel - Capricorn Venture Partners leads 1st financing round of € 3 million

Go to page

Merck Appoints Richard R. DeLuca Jr. as President, Merck Animal Health - Former Becton Dickinson and Wyeth Executive Joins Merck

Go to page

Movetis starts phase III clinical trial with prucalopride in male patients with chronic constipation

Go to page

Voyager Therapeutics & Genzyme collaborate to develop and commercialize novel AAV gene therapies for patients with CNS Disorders

Go to page

Aseptika Granted United States Patent for Biomarkers for Respiratory Infection Onset

Go to page

Vertex Pharmaceuticals: Start of Phase II Clinical Development for Investigational Oral Hepatitis C Virus Protease Inhibitor

Go to page

Eurofins expands its footprint in Asia with the acquisition of Lab Frontier in South Korea

Go to page